The device is designed to lower blood pressure while simultaneously modulating the autonomic nervous system by delivering ...

The biggest names in cardiac care gathered in San Diego for the Heart Rhythm Society (HRS) 2025 Annual Meeting.

Orchestra BioMed (Nasdaq:OBIO) received FDA breakthrough device designation for its atrioventricular interval modulation ...

Orchestra BioMed Holdings shares rallied premarket after the maker of medical devices said a blood-pressure mechanism received breakthrough status from the U.S. Food and Drug Administration, allowing ...

Orchestra BioMed’s hypertension treatment is the latest medical device to earn the FDA’s breakthrough designation. The device is an atrio-ventricular interval modulation therapy, meaning it ...

Beyond its income-generating capability, Medtronic's presence in the defensive healthcare sector provides significant advantages. The need for essential medical devices like pacemakers ...

“Hypertension remains a significant global public health challenge that is especially relevant to the pacemaker population as the most common comorbidity in these patients. Medtronic is ...

“Hypertension remains a significant global public health challenge that is especially relevant to the pacemaker population as the most common comorbidity in these patients. Medtronic is ...

CompanyOverview|NYSE:MDT] Investors increasingly seek stable and resilient investments in today's volatile and economically ...

Breakthrough Device Designation (“BDD”) applies to an estimated U.S. population of over 7.7 million patients with uncontrolled hypertension and increased cardiovascular risk BDD also encompasses ...